Newsletter | May 21, 2019

05.21.19 -- Strategies For The Future Of Biopharma

Guidelines To Bring Your Biologic To Market: Are You Prepared?

Are you up to the task of bringing a biologic to market? Do you have a strategy and plan in place? Explore some of the questions to consider in order to map out a successful pathway and avoid pitfalls.

Staying Flexible In Biomanufacturing

The concept of optionality is key to staying flexible in biomanufacturing by keeping your options open and having multiple pathways to take while navigating through this highly uncertain environment. 

Modular Bioprocessing Alleviates Drug Manufacturing Woes For BeiGene

Building a bioprocessing facility is usually a complicated process and requires partnering with not only drug developers, but also many different experts in various industries. BeiGene, a commercial-stage biotechnology company, can attest to these challenges.

Practical Considerations For Converting To A Ballroom Concept

Single-use technology is well-established and made its way into commercial licensed facilities, but there is more innovation in this field which will enhance its versatility into new markets and technologies.



Engage with the GE Healthcare Life Sciences team at BIO 2019

June 3-6, 2019, Philadelphia, PA Booth #3519


Make sure to schedule a meeting with one of our industry leaders on-site to discuss how we can help you advance speed to market, gain efficiency, and realize flexibility.


Don’t miss the Jefferson Institute of Bioprocessing tour in partnership with NIBRT and see the newest single-use training facility.


Engage with our Experts | Register for Tour